| Ticker | Company | May 2025 | May 2026 | 1Y Return | 52W High | 52W Low | vs. High | Market Cap | Analyst Consensus | P/E |
|---|---|---|---|---|---|---|---|---|---|---|
| SBGSY ★ | Schneider Electric | $49.74 | $63.00 | +26.7% | $66.47 | $49.03 | -5.2% | $175B | Buy (consensus) | 36.5x |
| ROK | Rockwell Automation | $311.15 | $451.06 | +45.0% | $457.94 | $311.15 | -1.5% | $51B | Buy | 46.5x |
| PH | Parker Hannifin | $658.97 | $844.63 | +28.2% | $1,020.71 | $646.59 | -17.3% | $108B | Strong Buy | 30.6x |
| AME | Ametek | $177.58 | $225.85 | +27.2% | $241.38 | $174.71 | -6.4% | $52B | Strong Buy | 33.8x |
| ETN | Eaton Corporation | $316.54 | $400.60 | +26.6% | $431.82 | $313.97 | -7.2% | $156B | Strong Buy | 39.0x |
| EMR | Emerson Electric | $117.47 | $143.82 | +22.4% | $160.42 | $116.96 | -10.3% | $79B | Buy | 33.0x |
| Analyst Firm | Rating | Date |
|---|---|---|
| J.P. Morgan | Buy | May 28, 2026 |
| Barclays | Buy | May 20, 2026 |
| DZ BANK AG | Buy | May 15, 2026 |
| Goldman Sachs | Buy | May 7, 2026 |
| Kepler Capital | Buy | May 5, 2026 |
| J.P. Morgan | Buy | May 5, 2026 |
| Bernstein | Buy | May 4, 2026 |
| Barclays | Buy | May 4, 2026 |
| Period | Report Date | Actual EPS | Est. EPS | Surprise | YoY EPS Change | Stock Reaction |
|---|---|---|---|---|---|---|
| H1 FY25 | Jul 31, 2025 | €0.909 | €0.979 | -7.2% MISS | +4.7% | -10.0% 🔴 |
| FY25 (Full Year) | Feb 26, 2026 | €1.093 | €1.136 | -3.8% MISS | +12.6% | +4.5% 🟢 |
| H1 FY24 | Jul 31, 2024 | €0.868 | €0.856 | +1.4% BEAT | +143.8% | -1.2% |
| FY24 (Full Year) | Feb 20, 2025 | €0.971 | €0.921 | +5.4% BEAT | +13.8% | +4.4% 🟢 |
| H1 FY23 | Jul 27, 2023 | €0.356 | €0.839 | -57.6% MISS ⚠ | -45.9% | +0.9% |
| FY23 (Full Year) | Feb 15, 2024 | €0.853 | €0.346 | +146.5% BEAT ⚠ | +3.3% | +3.8% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | 5Y Trend |
|---|---|---|---|---|---|---|
| Revenue | €28.9B | €34.2B | €35.9B | €38.2B | €40.2B | ↑ +39% total / ~8.5% CAGR |
| Gross Profit | €11.3B | €13.4B | €14.6B | €16.3B | €16.5B | ↑ Expanding |
| Gross Margin | 39.3% | 39.2% | 40.7% | 42.6% | 41.1% | ↑ +180bps over 5 years |
| EBITDA | €5.3B | €6.4B | €7.2B | €7.4B | €8.7B | ↑ +63% total |
| EBITDA Margin | 18.5% | 18.6% | 20.0% | 19.4% | 21.6% | ↑ Consistent expansion |
| Operating Income (EBIT) | €4.6B | €5.5B | €5.9B | €6.4B | €7.0B | ↑ +54% total |
| EBIT Margin | 15.8% | 16.2% | 16.5% | 16.9% | 17.5% | ↑ Every year (target: 20%+ by 2027) |
| Net Income | €3.2B | €3.5B | €4.0B | €4.3B | €4.2B | ↑ Strong |
| Net Margin | 11.1% | 10.2% | 11.2% | 11.2% | 10.4% | → Stable ~10-11% |
| EPS (Diluted, EUR) | €1.13 | €1.23 | €1.41 | €1.52 | €1.47 | ↑ Growing |
| R&D Expense | €1.3B | €1.5B | €1.7B | €2.2B | €2.1B | ↑ Accelerating (5.2% of rev.) |
| Free Cash Flow | €2.7B | €3.3B | €4.5B | €4.6B | €4.9B | ↑ +79% over 5 years — best-in-class |
| Net Debt | €8.2B | €7.7B | €9.2B | €9.4B | €13.1B | ↑ Rising (AVEVA + M&A) |
| Debt/Equity | 0.44x | 0.46x | 0.53x | 0.54x | 0.73x | ↑ Increasing but manageable |
| Metric | SBGSY ★ | ETN | ROK | AME | PH | EMR | Notes |
|---|---|---|---|---|---|---|---|
| P/E (Trailing) | 36.5x | 39.0x | 46.5x | 33.8x | 30.6x | 33.0x | SBGSY middle of pack |
| Market Cap | $175B | $156B | $51B | $52B | $108B | $79B | |
| FY2025 Revenue | €40.2B ($~44B) | ~$26B | ~$9B | ~$7B | ~$22B | ~$17B | Schneider is by far the largest |
| EBIT Margin (latest) | 17.5% | ~20% | ~17% | ~25% | ~23% | ~19% | Expanding toward 20%+ target |
| FCF Margin | ~12% | ~11% | ~12% | ~20% | ~15% | ~14% | |
| EV/EBITDA (est.) | ~22x | ~22x | ~25x | ~23x | ~18x | ~19x | Broadly in line with peers |
| Net Debt | €13.1B | ~$8B | ~$3B | ~$4B | ~$16B | ~$5B | Rising post-AVEVA acquisition |
| Debt / Equity | 0.73x | ~0.5x | ~0.6x | ~0.4x | ~1.2x | ~0.7x | Manageable; FCF deleveraging |
| Dividend Yield | 1.55% | 1.07% | 1.21% | 0.56% | 0.88% | 1.52% | SBGSY best yield in peer group |
| 1Y Stock Return | +26.7% | +26.6% | +45.0% | +27.2% | +28.2% | +22.4% | |
| Analyst Consensus | Buy (all banks) | Strong Buy | Buy | Strong Buy | Strong Buy | Buy | |
| Smart Score | 9 | 7 | 7 | 7 | 10 | 9 |
| Division | Est. Revenue | % of Total | Growth | Key Brands/Products |
|---|---|---|---|---|
| Energy Management | ~€28–29B | ~70–72% | +8–10% | Electrical distribution, grids, data centers, buildings |
| Industrial Automation | ~€11–12B | ~28–30% | ~flat | AVEVA, Modicon PLCs, OT/IT convergence |
| Year | Ex-Date | Amount (USD) | Yield at Payment | YoY Growth |
|---|---|---|---|---|
| 2026 | May 12, 2026 | $0.983 | 1.56% | +18.9% |
| 2025 | May 14, 2025 | $0.827 | 1.69% | +9.2% |
| 2024 | May 29, 2024 | $0.757 | 1.54% | +8.7% |
| 2023 | May 9, 2023 | $0.696 | 2.05% | +14.1% |
| 2022 | May 17, 2022 | $0.610 | 2.25% | -0.2% |
| 2021 | May 7, 2021 | $0.611 | 1.90% | +10.5% |
| 2020 | May 6, 2020 | $0.553 | 3.23% | +4.5% |
| 2019 | May 2, 2019 | $0.529 | 3.22% | -2.4% |
| MA | SMA Value | EMA Value | Signal |
|---|---|---|---|
| 5-day | $62.75 | $62.55 | Buy |
| 10-day | $61.80 | $62.37 | Buy |
| 20-day | $62.50 | $62.24 | Buy |
| 50-day | $60.33 | $61.11 | Buy |
| 100-day | $59.08 | $59.42 | Buy |
| 200-day | $56.55 | $56.87 | Buy |
| Factor | Signal | Detail |
|---|---|---|
| Revenue Growth | ✅ Strong | 8.5% CAGR 2021–2025; guided 7–10% for 2026 |
| Margin Expansion | ✅ On Track | EBIT margin 15.8% → 17.5%; targeting 20%+ by 2027 |
| Free Cash Flow | ✅ Best-in-class | €4.9B in FY2025; >100% conversion; growing every year |
| AI / Data Center Exposure | ✅ Direct | Power distribution, UPS, cooling for hyperscalers |
| Electrification Tailwind | ✅ 10–20 Year | Grid modernization, EVs, renewables integration |
| Leverage | ⚠ Moderate Risk | Net debt €13.1B (D/E 0.73x); rising post-AVEVA |
| Earnings Consistency | ⚠ Mixed | 2 of last 4 reports were misses (H1 FY25: -7.2%) |
| Dividend | ✅ Growing | ~9% DPS CAGR; 58% payout ratio; EUR-denominated |
| Valuation vs. Peers | → Fair | 36.5x P/E in line with electrification peer median |
| Currency Risk | ⚠ Present | EUR/USD moves directly affect USD ADR returns |
| Factor | ABBV (AbbVie) | SBGSY (Schneider Electric) | Edge |
|---|---|---|---|
| Sector | Healthcare / Pharma | Industrials / Electrification | Different |
| 1Y Return | +20.8% | +26.7% | SBGSY |
| Smart Score | 10 / 10 | 9 / 10 | ABBV |
| Hedge Fund Score | 1.00 (Perfect) | 0.50 (ADR float only) | ABBV |
| Analyst Consensus | Strong Buy (16B/4H/0S) | Buy (all majors, 100% Buy) | Tied |
| Dividend Yield | 3.10% | 1.55% | ABBV |
| Dividend Growth | ~5–6% annually | ~9–10% annually (EUR basis) | SBGSY |
| Revenue Growth | ~8–9% (FY2025) | ~8–9% CAGR | Tied |
| Earnings Consistency | 8/8 beats | 2 misses in last 4 reports | ABBV |
| FCF Generation | $17.8B (pharma scale) | €4.9B (growing strongly) | Context-dependent |
| P/E (Trailing) | 106x GAAP / ~13–14x adj. | 36.5x GAAP | SBGSY (cleaner metric) |
| Technical Setup | Overbought oscillators | RSI 53, room to run | SBGSY |
| Near-Term Risk Event | Q2 FY26 earnings Jul 24 | H1 FY26 earnings Jul 30 (prior miss: -10%) | ABBV |
| Macro Tailwind | Immunology drugs (duopoly) | Electrification + AI infra (megatrend) | SBGSY |
| Debt Level | $63.8B net debt | €13.1B net debt (lower relative) | SBGSY |